Navigation Links
Isis Reports Financial Results and Highlights for Second Quarter of 2008
Date:8/7/2008

al revenue has been classified as research and

development revenue under collaborative agreements on Isis' condensed

consolidated statement of operations.

(2) Ibis' cost of commercial revenue has been classified as research and

development expenses on Isis' condensed consolidated statement of

operations.

Regulus Therapeutics LLC

Statements of Operations

(In Thousands)

Three Months Six Months

Ended Ended

June 30, 2008 June 30, 2008

Revenue:

Research and development revenue under

collaborative agreements $656 $748

Total revenue 656 748

Expenses:

Research and development 1,606 2,918

General and administrative 917 1,132

Total operating expenses 2,523 4,050

Loss from operations $(1,867) $(3,302)

Regulus was formed in the third quarter of 2007; therefore it does not have operating results for the first half of 2007.

Isis Pharmaceuticals, Inc.

Condensed Consolidated Balance Sheets

(In Thousands)

June 30, December 31,

2008 2007

(unaudited)

Assets:

Cash, cash equivalents and short-term

investments $536,969 $193,719

Other current assets
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Barr Reports Second Quarter 2008 GAAP Earnings of $0.52 Per Share; Adjusted Earnings of $0.64 Per Share
2. PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results
3. Caliper Life Sciences Reports Second Quarter 2008 Results
4. Watson Pharmaceuticals Reports Second Quarter 2008 Results
5. EntreMed Reports Second Quarter 2008 Financial Results
6. Transgenomic Reports Second Quarter 2008 Results
7. Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
8. Bionovo Reports Second Quarter 2008 Financial Results
9. AtriCure Reports Record Second Quarter 2008 Financial Results
10. AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008
11. eResearchTechnology Reports Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... -- Research and Markets  has announced the addition of ... Business Report" report to their offering. ... Cells (SOFCs) in US$ Thousands. The report provides separate comprehensive ... Europe , Asia-Pacific , and ... the period 2012 through 2020. Market data and analytics are ...
(Date:8/19/2014)... Research and Markets ... "Spectroscopy Equipment and Accessories - Global Strategic ... This report analyzes the ... in US$ Thousands by the following Product ... NMR-EPR Spectrometers, Near Infrared (NIR) Spectrometers, IR ...
(Date:8/19/2014)... Aug. 19, 2014   Synthetic Biologics, Inc. ... novel anti-infective biologic and drug programs targeting specific ... today that its novel C. difficile ... th Interscience Conference on Antimicrobial Agents and ... D.C. Synthetic Biologics, Senior ...
(Date:8/18/2014)... (PRWEB) August 19, 2014 2014 ... Industryā€¯ is a professional and in-depth research report ... basic Linalool information, including its definition, classification, ... industry overview. This research covers the international market ... global industry analysis covering macroeconomic environment & economic ...
Breaking Biology Technology:Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014 2Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 4Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 2Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 4
... 2011 VIGILAIR Systems, an industry leader ... a newly published, and first of its kind hospital ... Acquired Infections (HAI) with the application of VIGILAIR® air ... The published article , Effect of enhanced ...
... Calif., April 8, 2011 Sangamo BioSciences, Inc. (Nasdaq: ... announced public offering of 6,700,000 shares of its common stock ...  The public offering is expected to close on or around ... Capital Inc. is the sole book-running manager in this offering ...
... 7, 2011 Cephalon, Inc. (NASDAQ: CEPH ... filed with the Securities and Exchange Commission (SEC) that ... Valeant Pharmaceuticals International, Inc.,s proposals to remove and replace ... consent solicitation cards to Valeant.  On April 5, 2011, ...
Cached Biology Technology:Newly Published Study Shows Dramatic Reduction in Hospital Acquired Infections 2Sangamo Announces Pricing of Public Offering of Common Stock 2Sangamo Announces Pricing of Public Offering of Common Stock 3Cephalon Recommends Shareholders Reject Valeant Nominees 2Cephalon Recommends Shareholders Reject Valeant Nominees 3Cephalon Recommends Shareholders Reject Valeant Nominees 4Cephalon Recommends Shareholders Reject Valeant Nominees 5
(Date:8/20/2014)... past few years, Virginia Tech,s Wu Feng has built ... from the "Computing in the Cloud" program, and synergistically ... million award from the Air Force on "big computing" ... and the National Institutes of Health on "big data" ... the "parallel computing" aspects from each grant, he was ...
(Date:8/20/2014)... University researchers have developed methods for electronically manipulating the ... signals moths use to control those muscles. The work ... or "biobots," for use in emergency response. , "In ... can control the movement of moths for use in ... Alper Bozkurt, an assistant professor of electrical and computer ...
(Date:8/19/2014)... 19, 2014 To improve students, chances of ... the University of Houston (UH) implemented a comprehensive ... at risk for failure. , Through a ... (THECB), the Department of Biology and Biochemistry embarked ... taking "General Biology" for non-majors and "Introductory Biology" ...
Breaking Biology News(10 mins):The internet was delivered to the masses; parallel computing is not far behind 2The internet was delivered to the masses; parallel computing is not far behind 3The internet was delivered to the masses; parallel computing is not far behind 4Research paves way for development of cyborg moth 'biobots' 2University of Houson program earns kudos for improving grades, retaining students 2University of Houson program earns kudos for improving grades, retaining students 3
... reside in designated Special Areas of Conservation throughout the ... risk from pile driving. The frequency range of pile ... find food and avoid predators. This has the potential ... breed successfully. Lactating females and young calves might be ...
... Special Areas of Conservation throughout the UK, including Dorset, ... driving. The frequency range of pile driving noise could ... avoid predators. This has the potential to affect their ... females and young calves might be particularly vulnerable ...
... fruits and vegetables to their daily diets. Now, UC Davis ... the kinds of cellular activity that leads to the development ... "We've known for a long time that it's the flavonoids ... known exactly how. Now, at least in the case of ...
Cached Biology News:South Pacific plant may be missing link in evolution of flowering plants 2Dolphins at risk 2UC Davis researchers reveal apples' protective ways 2
Phospho-FAK (Tyr576/577) Antibody...
... Anti-Natural Killer Cell Receptor-P1, ... Immunogen: Hybridoma produced ... from BALB/c mice immunized (BALB/c ... (LAK) cells and mouse myeloma ...
... to Yersinia pestis This antibody ... . Immunogen: Purified ... vaccine strain EV76. ... F1 capsular antigen. There is no ...
Rabbit polyclonal to ZFP200 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CGKSFNHKTNLNKHER (Human) Entrez Gene ID: 7752 Swiss Protein ID: P98182...
Biology Products: